Funders · Entity Annotation Prototype (beta)

2articles mentioning funders

2funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: ACTRN12618001211257 ×

ACTRN12618001211257

This funder is selected. Its supporting articles are shown below.

ACTRN126180012112572

Articles mentioning ACTRN12618001211257

2 articles · page 1 of 1

Performance of an individualized, subcutaneous, basal-bolus insulin regimen for the management of prednisolone-associated hyperglycemia in hospitalized patients: a proof-of-concept study

bmjdrc · abstract · 2025-11-09 · 1 matching annotations

76.6%

ACTRN12618001211257 Prednisolone prednisolone-associated hyperglycemia

…duced short-term glycemic variability.Trial registration number ACTRN12618001211257.…

Performance of an individualized, subcutaneous, basal-bolus insulin regimen for the management of prednisolone-associated hyperglycemia in hospitalized patients: a proof-of-concept study

bmjdrc · full text · 2025-11-09 · 1 matching annotations

78.0%

ACTRN12618001211257 diabetes prednisolone type 2 diabetes T2DM insulin aspart

…tered with the Australian New Zealand Clinical Trials Registry (ACTRN12618001211257).The standard treatment group comprised 24 adults from a previo…

Browse funders

ACTRN12618001211257

Articles mentioning ACTRN12618001211257

Performance of an individualized, subcutaneous, basal-bolus insulin regimen for the management of prednisolone-associated hyperglycemia in hospitalized patients: a proof-of-concept study

Performance of an individualized, subcutaneous, basal-bolus insulin regimen for the management of prednisolone-associated hyperglycemia in hospitalized patients: a proof-of-concept study